GPT and metabolic dysfunction-associated steatohepatitis: Our present results are in agreement with the improvement of several independent predictors of NASH described by Ballestri et al. [38] such as insulin resistance, plasma total cholesterol and ALT as well as to a decrease in plasma triglycerides and hepatic total fat and triglyceride content.